Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 9
Submit an article Journal homepage
852
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia

Lydia L. Beniteza Michigan Medicine, Ann Arbor, MI, USA;b College of Pharmacy, University of Michigan, Ann Arbor, MI, USACorrespondence[email protected]
View further author information
,
Anthony J. Perissinottia Michigan Medicine, Ann Arbor, MI, USAView further author information
,
Caitlin R. Rauschc The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jeff Klausd Barnes Jewish Hospital, St. Louis, MO, USAView further author information
,
Stephen Michael Clarke University of North Carolina Medical Center, Chapel Hill, NC, USAView further author information
,
Michael Filtzf Huntsman Cancer Institute, Salt Lake City, UT, USAView further author information
,
Kelley Ratermannf Huntsman Cancer Institute, Salt Lake City, UT, USAView further author information
,
Carissa Treptowg Department of Pharmacy, University of Rochester, Rochester, NY, USAView further author information
,
Shawn Griffinh Indiana University Health, Indianapolis, IN, USAView further author information
,
Marissa Olsond Barnes Jewish Hospital, St. Louis, MO, USAView further author information
,
Mallory Craind Barnes Jewish Hospital, St. Louis, MO, USAView further author information
,
Tapan Kadiac The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Kristen Pettita Michigan Medicine, Ann Arbor, MI, USAView further author information
,
Patrick W. Burkea Michigan Medicine, Ann Arbor, MI, USAView further author information
,
Dale L. Bixbya Michigan Medicine, Ann Arbor, MI, USAView further author information
&
Bernard L. Marinia Michigan Medicine, Ann Arbor, MI, USA;b College of Pharmacy, University of Michigan, Ann Arbor, MI, USAView further author information
 show all
Pages 2184-2192 | Received 14 Oct 2020, Accepted 08 Mar 2021, Published online: 08 Apr 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniel Cacic Limi & Håkon Reikvam. (2023) Liposomal drug formulations for treatment of hematological malignancies. Expert Opinion on Pharmacotherapy 0:0, pages 1-4.
Read now

Articles from other publishers (7)

Roberto M. Lemoli, Pau Montesinos & Akriti Jain. (2023) Real-world experience with CPX-351 in high-risk acute myeloid leukemia. Critical Reviews in Oncology/Hematology 185, pages 103984.
Crossref
Jennifer H. Cooperrider, Navika Shukla, Mariam T. Nawas & Anand Ashwin Patel. (2023) The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia. JCO Oncology Practice 19:2, pages 74-85.
Crossref
Franziska Modemann, Susanne Ghandili, Carsten Bokemeyer & Walter Fiedler. (2022) Erstlinientherapie intensiv-therapierbarer AML-Patient*innen. InFo Hämatologie + Onkologie 25:7-8, pages 16-21.
Crossref
Madeleine A. Ochs, Bernard L. Marini, Anthony J. Perissinotti, Charles E. Foucar, Kristen Pettit, Patrick Burke, Dale L. Bixby & Lydia L. Benitez. (2022) Oncology stewardship in acute myeloid leukemia. Annals of Hematology 101:8, pages 1627-1644.
Crossref
Paulina Stefaniuk, Agnieszka Szymczyk & Monika Podhorecka. (2022) In Pursuit of Genetic Prognostic Factors and Treatment Approaches in Secondary Acute Myeloid Leukemia—A Narrative Review of Current Knowledge. Journal of Clinical Medicine 11:15, pages 4283.
Crossref
Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar I. Gill, David L. Porter, Daria V. Babushok, Ivan P. Maillard, Martin P. Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei-Ting Hwang, David Margolis & Keith W. Pratz . (2022) Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Blood Advances 6:13, pages 3997-4005.
Crossref
Adam S. Zayac & John L. Reagan. (2021) Trials and Tribulations in the Frontline Treatment of Older Adults with Acute Myeloid Leukemia. Hemato 2:3, pages 515-544.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.